NOVEL APPROACH FOR THE PREVENTION OF RECURRENT HEPATITIS C IN LIVER TRANSPLANT RECIPIENTS: PRELIMINARY RESULTS FROM ONGOING PHASE III TRIAL WITH CIVACIR (R) Article
Full Text via DOI: 10.1016/S0168-8278(15)30171-9
Web of Science: 000361967600171